Drugs@FDA document

FLUDEOXYGLUCOSE F18 Review · NDA 020306 SUPPL-5

Drugs@FDA document · DOWNSTATE CLINCL · Mar 10, 2004

Key facts

Drug name FLUDEOXYGLUCOSE F18
Document type Review
Application NDA020306
Submission SUPPL-5
Company DOWNSTATE CLINCL
Document date Mar 10, 2004
FDA document accessdata.fda.gov

At a glance

  • Efficacy-New Indication Document categories
  • 1–9 Documents for this application
  • None USP chapters cited in this application's documents

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Drugs@FDA documents

Drugs@FDA posts the letters, labels, reviews and other documents behind each drug application and supplement. Orca1 indexes every document's full text and flags complete response letters.

Source: U.S. Food and Drug Administration (FDA), Drugs@FDA application documents · Source date:

Browse all Drugs@FDA documents